The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study

Abstract Objectives We aimed to report our 10-year experience of treating short children born small for gestational age (SGA) by comparing the long-term growth, metabolic safety, and cost-effectiveness of recombinant human growth hormone (rhGH) therapy in short children born SGA with those in rhGH-treated children with growth hormone deficiency (GHD) and Turner syndrome. Methods We performed a 10-year retrospective cohort study at King Saud University Medical City. We included children aged 3–16 years who received rhGH for GHD, SGA, or Turner syndrome for >1 year. Results A total of 166 children received rhGH therapy for GHD, 58 for SGA, and 16 for Turner syndrome. During the last study visit, the average height change was 21 cm for GHD children and 14 cm for children born SGA (p-value <0.001). The height SDS change was 0.84 for GHD children and 0.55 for SGA children (p-value=0.004). The average cost-effectiveness ratios for treating GHD and SGA children were USD 1,717.22 and USD 1,157.19 per centimeter gained, respectively. Moreover, the mean incremental cost-effectiveness ratio for GHD vs. SGA patients was USD 2,820.39 per centimeter gained. Dysglycemia developed in 70 patients: 43 (36.44%), 22 (40.74%), and 5 (13%) in the GHD, SGA, and Turner syndrome groups, respectively. Conclusions rhGH is effective in height improvement of short children. However, pursuing rhGH treatment for children born SGA requires a shared decision-making approach to balance the modest benefit of final adult height gain with the long-term metabolic effects, considering the acceptable costs on the Saudi healthcare system.

[1]  J. Martínez,et al.  Low birth weight and small for gestational age are associated with complications of childhood and adolescence obesity: Systematic review and meta‐analysis , 2021, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[2]  W. Cutfield,et al.  The Auxological and Metabolic Consequences for Children Born Small for Gestational Age , 2021, Indian Journal of Pediatrics.

[3]  Z. Aycan,et al.  Evaluation of Growth Hormone Results in Different Diagnosis and Trend Over 10 Year of Follow-up: A Single Center Experience , 2021, Journal of clinical research in pediatric endocrinology.

[4]  Hae-sang Lee,et al.  Factors influencing growth hormone therapy effect during the prepubertal period in small for gestational age children without catch-up growth , 2021, Annals of pediatric endocrinology & metabolism.

[5]  M. Pakdaman,et al.  Cost-effectiveness of Growth Hormone and its Consumption Indications: A Systematic Review of Economic Evaluation Studies , 2021, Health Technology Assessment in Action.

[6]  D. Dunger,et al.  What is the evidence for beneficial effects of growth hormone treatment beyond height in short children born small for gestational age? A review of published literature , 2019, Journal of pediatric endocrinology & metabolism : JPEM.

[7]  I. Hwang.  Long-term care, from neonatal period to adulthood, of children born small for gestational age , 2019, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[8]  Toshiaki Tanaka,et al.  Efficacy and safety of growth hormone treatment in Japanese children with small-for-gestational-age short stature in accordance with Japanese guidelines , 2018, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[9]  J. Ross,et al.  Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS) , 2018, Hormone Research in Paediatrics.

[10]  Raoul Rooman,et al.  Adult Height after Growth Hormone Treatment at Pubertal Onset in Short Adolescents Born Small for Gestational Age: Results from a Belgian Registry-Based Study , 2018, International journal of endocrinology.

[11]  Toshiaki Tanaka,et al.  Evaluation of growth hormone treatment efficacy in short Japanese children born small for gestational age: Five-year treatment outcome and impact on puberty , 2017, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[12]  C. Polychronakos,et al.  Guidelines for Growth Hormone and Insulin-Like Growth Factor-I Treatment in Children and Adolescents: Growth Hormone Deficiency, Idiopathic Short Stature, and Primary Insulin-Like Growth Factor-I Deficiency , 2016, Hormone Research in Paediatrics.

[13]  M. Savage,et al.  Diagnosis and management of growth disorders in Gulf Cooperation Council (GCC) countries: Current procedures and key recommendations for best practice , 2016, International journal of pediatrics & adolescent medicine.

[14]  A. Pasquino,et al.  Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study , 2015, Journal of Endocrinological Investigation.

[15]  J. Rotteveel,et al.  New insights into factors influencing adult height in short SGA children: Results of a large multicentre growth hormone trial , 2015, Clinical endocrinology.

[16]  M. Maruszczak,et al.  The who-choice cost-effectiveness Threshold: a Country-level analysis of changes over time , 2015 .

[17]  Toshiaki Tanaka,et al.  Onset of puberty and near adult height in short children born small for gestational age and treated with GH: Interim analysis of up to 10 years of treatment in Japan , 2015, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

[18]  H. Wollmann,et al.  Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS. , 2014, The Journal of clinical endocrinology and metabolism.

[19]  H. Christesen,et al.  Comparison of response to 2-years’ growth hormone treatment in children with isolated growth hormone deficiency, born small for gestational age, idiopathic short stature, or multiple pituitary hormone deficiency: combined results from two large observational studies , 2012, International Journal of Pediatric Endocrinology.

[20]  Nada S. Al-Qadheeb,et al.  Pharmacoeconomic Analysis in Saudi Arabia: An Overdue Agenda Item for Action , 2011, Annals of Saudi medicine.

[21]  L. Dunkel,et al.  A Comparison of Different Definitions of Growth Response in Short Prepubertal Children Treated with Growth Hormone , 2011, Hormone Research in Paediatrics.

[22]  M. Ranke,et al.  Height at Start, First-Year Growth Response and Cause of Shortness at Birth Are Major Determinants of Adult Height Outcomes of Short Children Born Small for Gestational Age and Silver-Russell Syndrome Treated with Growth Hormone: Analysis of Data from KIGS , 2010, Hormone Research in Paediatrics.

[23]  A. Maiorana,et al.  Impact of Growth Hormone Therapy on Adult Height of Children Born Small for Gestational Age , 2009, Pediatrics.

[24]  W. Blum,et al.  Growth hormone treatment for short stature in children born small for gestational age , 2008, Advances in therapy.

[25]  M. E. El Mouzan,et al.  Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study , 2008, Annals of Saudi medicine.

[26]  K. Itabashi,et al.  Longitudinal follow-up of height up to five years of age in infants born preterm small for gestational age; comparison to full-term small for gestational age infants. , 2007, Early human development.

[27]  P. Czernichow,et al.  CONSENSUS STATEMENT: Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society , 2007 .

[28]  Xinli Wang,et al.  Glucose and lipid metabolism in small-for-gestational-age infants at 72 hours of age. , 2007, The Journal of clinical endocrinology and metabolism.

[29]  A. Hokken-Koelega,et al.  Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls. , 2007, The Journal of clinical endocrinology and metabolism.

[30]  R. Simmons.  Developmental origins of adult metabolic disease: concepts and controversies , 2005, Trends in Endocrinology & Metabolism.

[31]  F. de Zegher,et al.  Growth Hormone Therapy for Children Born Small for Gestational Age: Height Gain Is Less Dose Dependent Over the Long Term Than Over the Short Term , 2005, Pediatrics.

[32]  A. Hokken-Koelega,et al.  Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial. , 2003, The Journal of clinical endocrinology and metabolism.

[33]  S. Cnattingius,et al.  Prediction of Male Adult Stature Using Anthropometric Data at Birth: A Nationwide Population-Based Study , 1999, Pediatric Research.

[34]  A. Hokken-Koelega,et al.  Growth hormone treatment in children with short stature born small for gestational age: 5-year results of a randomized, double-blind, dose-response trial. , 1999, The Journal of clinical endocrinology and metabolism.

[35]  R N Bergman,et al.  Insulin resistance in short children with intrauterine growth retardation. , 1997, The Journal of clinical endocrinology and metabolism.

[36]  M. Ranke,et al.  Growth hormone treatment of short children born small for gestational age or with Silver–Russell syndrome: results from KIGS (Kabi International Growth Study), including the first report on final height , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[37]  A. Hokken-Koelega,et al.  Children Born Small for Gestational Age: Do They Catch Up? , 1995, Pediatric Research.

[38]  K. Albertsson-Wikland,et al.  Natural growth in children born small for gestational age with and without catch‐up growth , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.